tetradecanoylphorbol acetate has been researched along with clenbuterol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Samina Riaz , S; Tomlinson, DR | 1 |
Bross, T; Geiger, KK; Hoetzel, A; Humar, M; Loop, T; Pahl, HL; Pannen, BHJ; Schmidt, R | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and clenbuterol
Article | Year |
---|---|
Pharmacological modulation of nerve growth factor synthesis: a mechanistic comparison of vitamin D receptor and beta(2)-adrenoceptor agonists.
Topics: 3T3 Cells; 8-Bromo Cyclic Adenosine Monophosphate; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Antineoplastic Agents; Calcitriol; Carcinogens; Clenbuterol; Colforsin; Gene Expression; Mice; Nerve Growth Factor; NF-kappa B; Propranolol; Receptors, Calcitriol; RNA, Messenger; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Transcription, Genetic | 2000 |
Dobutamine inhibits phorbol-myristate-acetate-induced activation of nuclear factor-kappaB in human T lymphocytes in vitro.
Topics: Adrenergic Agents; Adrenergic beta-Agonists; Anti-Inflammatory Agents; CD3 Complex; Cell Nucleus; Clenbuterol; DNA; Dobutamine; Electrophoretic Mobility Shift Assay; Humans; Jurkat Cells; NF-kappa B; Receptors, Adrenergic, alpha; T-Lymphocytes; Tetradecanoylphorbol Acetate; Xamoterol | 2004 |